dpp4 with glp 1 Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease Cardiovascular effects of DPP-4 inhibition:

Physicians must recognise that no single treatment is suitable for all patients or clinical situations, as detailed in the previous sections.

While these findings support the expanding role of GLP-1RAs beyond glycemic and cardiometabolic control, the authors caution that randomized trials are needed to establish a causal relationship and assess long-term safety for neuroprotective outcomes

Investigations into YTHDF1 concerning tumor metabolism and stress responses in cells have shown its significant role in managing cellular functions

W porwnaniu do grupy placebo, nawilenie skry, zuszczanie, zmarszczki i elastyczno znacznie poprawiy si po odpowiednio 4, 4, 12 i 12 tygodniach podawania CPNS